Skip to main content

Christopher Martin

Equibles does not estimate personal net worth.

Get an email with a short summary when Edgewise Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get EWTX alerts

About Christopher Martin

Christopher Martin is recorded as Board Member at Edgewise Therapeutics, Inc. (EWTX) since November 19, 2025. Edgewise Therapeutics, Inc. reported in an 8-K filed November 20, 2025 that Christopher Martin was appointed Class I director, effective November 19, 2025. Edgewise Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Edgewise Therapeutics, Inc. includes Kevin Koch (CEO and Board Member), Michael P. Nofi (CFO), R. Michael Carruthers (CFO) and 5 others.

“On November 19, 2025, the Board of Directors (the "Board") of Edgewise Therapeutics, Inc. (the "Company") appointed Christopher Martin to serve as a Class I director, with a term expiring at the Company's 2028 annual meeting of stockholders.”
Edgewise Therapeutics, Inc. Form 8-K, filed November 20, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Edgewise Therapeutics, Inc.

Recent activity